EFFICACY AND SAFETY IN KEY PATIENT SUBGROUPS OF NIVOLUMAB (NIVO) ALONE OR COMBINED WITH IPILIMUMAB (IPI) VERSUS IPI ALONE IN TREATMENT-NAIVE PATIENTS WITH ADVANCED MELANOMA (MEL) (CHECKMATE 067)

被引：0

作者：

Larkin, James ^{[1
]}

Chiarion-Sileni, Vanna ^{[2
]}

Gonzalez, Rene ^{[3
]}

Grob, Jean-Jacques ^{[4
]}

Cowey, C. Lance ^{[5
]}

Lao, Christopher D. ^{[6
]}

Wagstaff, John ^{[7
]}

Hogg, David ^{[8
]}

Hill, Andrew ^{[9
]}

Carlino, Matteo S. ^{[10
,11
]}

Wolter, Pascal ^{[12
]}

Lebbe, Celeste ^{[13
]}

Schachter, Jacob ^{[14
]}

Thomas, Luc ^{[15
]}

Hassal, Jessica C. ^{[16
]}

Lorigan, Paul ^{[17
]}

Walker, Dana ^{[18
]}

Jiang, Joel ^{[19
]}

Hodi, F. Stephen ^{[20
]}

Wolchok, Jedd D. ^{[21
]}

机构：

[1] Royal Marsden Hosp, London SW3 6JJ, England

[2] IOV IRCCS, Melanoma Oncol Unit, Padua, Italy

[3] Univ Colorado, Ctr Canc, Denver, CO 80262 USA

[4] Aix Marseille Univ, Hop La Timone, APHM, Marseille, France

[5] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA

[6] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[7] Singleton Hosp, South West Wales Canc Inst, Swansea SA2 8QA, W Glam, Wales

[8] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada

[9] Tasman Oncol Res, South Port Gold Coast, Qld, Australia

[10] Melanoma Inst Australia, Sydney, NSW, Australia

[11] Univ Sydney, Sydney, NSW 2006, Australia

[12] UZ Leuven, Leuven, Belgium

[13] Univ Paris Diderot, Hop St Louis, Paris, France

[14] Inst Oncol, Tel Hashomer, Israel

[15] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France

[16] German Canc Res Ctr Univ Hosp, Heidelberg, Germany

[17] Christie NHS Fdn Trust, Manchester, Lancs, England

[18] Bristol Myers Squibb Co, Princeton, NJ USA

[19] Bristol Myers Squibb Co, Hopewell, NJ USA

[20] Dana Farber Canc Inst, Boston, MA 02115 USA

[21] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

Asia-Pacific Journal of Clinical Oncology | 2015年 / 11卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

204

引用

页码：126 / 126

页数：1